No menu items!
No menu items!
HomeHealth NewsAI in Clinical Trials market 2023 – Industry Growth by 2035

AI in Clinical Trials market 2023 – Industry Growth by 2035

Driven by the diverse advantages and ongoing advancements in AI, the demand for AI software and services in clinical trials has increased in the healthcare industry. As a result, clinical trial sponsors have started utilizing AI to streamline clinical trials and obtain desired patient outcomes, resulting in a more patient-centric, time and cost-effective, and easy to manage approach.


The financial opportunity within the artificial intelligence in clinical trials market has been analysed across the following segments:


  • Trial Phase
  • Phase I
  • Phase II
  • Phase III


  • Target Therapeutic Area
  • Oncological Disorders
  • Cardiovascular Disorders
  • CNS Disorders
  • Infectious Diseases
  • Metabolic Disorders
  • Other Disorders


  • End-User
  • Biotechnology and Pharmaceutical Companies
  • Academic Research Institute and Other end-users


  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America


Table of Contents


  1. Preface

    2. Executive Summary

  2. Introduction
  3. Market Landscape
  4. Artificial intelligence companies Profiles
  5. Clinical Trial Analysis
  6. Partnerships and Collaborations
  7. Funding and Investment Analysis
  8. Big Pharma Initiatives


  1. AI in Clinical Trials: Use Cases


  1. Value Creation Framework: A Strategic Guide to Address Unmet Needs in Clinical Trials


  1. Cost Saving Analysis


  1. Market Forecast and Opportunity Analysis
  2. Conclusion


  1. Executive Insights


  1. Appendix I: Tabulated Data


  1. Appendix II: List of Companies and Organizations


To view more details on this report, click on the link


Learn from experts:  do you know about these emerging industry trends?

Transformation of Biopharmaceuticals Manufacturing Through Single-use Bioreactors

Liposome: A Novel Drug Delivery System


About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.


Learn more about Roots Analysis consulting services: 

Connect with our Roots Analysis Consulting team: For your custom research exclusive best-in-class quality projects



Ben Johnson

+1 (415) 800 3415